FDA News Digest August 19, 2002 _______________________________________________________ FDA's Top Official Issues Statement on Metabolife FDA Deputy Commissioner Dr. Lester M Crawford says FDA has asked the Justice Department to pursue a criminal investigation of Metabolife regarding possible false statements made to FDA about the existence of adverse event reports related to the company's products. http://www.fda.gov/bbs/topics/NEWS/2002/NEW00828.html ________________________________________________________________ Tissue-Processing Company Ordered to Recall Materials FDA has ordered Georgia-based Cryolife Inc. to recall distributed human tissue processed from Oct. 3, 2001 to the present. FDA is taking this action because the agency has determined that Cryolife cannot ensure that the human tissue it processes for transplantation is free from fungal and bacterial contaminants. http://www.fda.gov/bbs/topics/NEWS/2002/NEW00827.html ________________________________________________________________ Public Should Avoid Chinese Diet Pills With Fenfluramine Following reports from Japan of sickness and death associated with certain Chinese weight-loss products that contain fenfluramine, FDA has warned consumers to avoid these products. http://www.fda.gov/bbs/topics/NEWS/2002/NEW00826.html ________________________________________________________________ Mammography Advisory Committee to Meet Aug. 26 FDA's National Mammography Quality Assurance Advisory Committee will have a public meeting Aug. 26 in Gaithersburg, Md. The agenda includes discussion of potential new applications of full-field digital mammography and changes to compliance guidance for the Mammography Quality Standards Act. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfAdvisory/details.cfm?mtg =346 _________________________________________________________________ Thanks for subscribing to the FDA News Digest. Our next posting will be August 26. To leave this list at any time, send an e-mail to LISTSERV@LIST.NIH.GOV In the body of the message, write SIGNOFF FDA-NEWSDIGEST-L
